Symposium Menu

HTRS 2023 Home


Schedule of Events

Faculty & Presenters



Hotel Information

Continuing Education

Travel Awards

Member Recognition Awards

Sponsors & Exhibitors 

General Information

We highly encourage you to join the HTRS mailing list to stay up-to-date on the latest HTRS 2023 news.

Email [email protected] to be added to our list.

Follow us on Twitter @HTRSToday



The abstract/poster session at HTRS 2023 is a forum for presenting original clinical, translational, or basic science research in hemostasis and thrombosis.


 General Information

HTRS accepts abstracts focused on disorders of hemostasis and/or thrombosis from:

  • Students – Medical/Nursing, Graduate, Veterinary, PharmD
  • Post-Doctoral Trainees – PhDs, Residents, Fellows
  • Faculty – MD, PhD, Pharmacy, Nursing, Other
  • Research Scientists – Academic, Industry, Government
  • Advanced Practice Providers - Nurses, Nurse Practitioners Physician Assistants, Pharmacists, Physical Therapists, Medical Technologists, Genetic Counselors & Social Workers

Authors of accepted abstracts may be invited to present their abstracts as oral presentations or posters during the meeting. Accepted abstracts will be published in an online issue of Research and Practice in Thrombosis and Haemostasis (RPTH), the Open Access journal of the International Society on Thrombosis and Haemostasis (ISTH), which provides a dedicated home for science and discourse among researchers, clinicians, nurses, allied health professionals, and patients. 

Abstracts submitted in the “Informational Only” category described in Section 8 of the submission guidelines may be accepted as posters, but are not eligible for awards, oral presentations, or publication in RPTH.

Authors of accepted abstracts who go on to write a journal article based on their research are highly encouraged to submit their article to RPTH.


 Submission Deadline

DEADLINE EXTENSION: Abstract submissions are due on or before Friday, October 28, 2022 at 11:59 PM ET.

After this deadline, abstracts cannot be revised or resubmitted. Only online submissions through the HTRS Abstract Submission Portal are considered.

After successfully submitting an abstract, authors may log in to the portal until the deadline to make edits. Late abstracts will not be accepted.

The submission link provided above will be deactivated at 12:00 AM ET on Saturday, October 29, 2022.


 Travel Awards

HTRS has increased the number of Travel Awards available in 2023 for medical trainees (residents and fellows), junior faculty, early-stage investigators, minorities, and advanced practice providers. We encourage applications even if the meeting is held virtually. Awards will still be given for outstanding abstract submissions to a virtual meeting, and recipients will still be recognized during the meeting.
Abstract submitters interested in applying for a Travel Award must complete the corresponding sections of the submission form to be considered for an award.

More information on applying for an award can be found on the Travel Awards page.


HTRS Abstract Acceptance Policy

Abstracts will be accepted by HTRS if submitting authors meet the following criteria:

  • Abstracts should describe original work.
    • Abstracts must contain new data. Abstracts previously presented at a national or international meeting may not be submitted without modification; data must be updated or expanded, resulting in a new abstract.
    • Any abstracts previously presented in a substantive way must be accompanied by a justification statement (or appeal) of three sentences or less to explain why the abstract should be accepted for presentation at HTRS. The HTRS Review Committee will consider such appeals.
    • Data featured in the abstract may not be published before presentation at the meeting. HTRS reserves the right to decline previously published abstracts.
    • The abstract/data submitted to HTRS should not be submitted to other meetings before the HTRS 2023 Symposium takes place. After the 2023 meeting, the abstract may be submitted as an encore item to other meetings if their policy allows.
  • The Presenter must be an author of the abstract; if the abstract is a "presentation on behalf of X study group," the presenter must be a member of said study group.
  • The title and body of the abstract must not contain:
    • Personal patient information
    • Studies reporting unidentified chemical compounds, drugs, or materials
    • Non-generic drug names (generic drug names may be used in a footnote at the bottom of the abstract)
    • The title of the abstract must not contain commercial company names (commercial company names may be used in the body of the abstract or as a footnote of the abstract if the name thereby better identifies a product or device)
  • The submitting author will be asked to certify the following statements prior to uploading an abstract to the online submission site:
    • The reported research complies with all applicable animal welfare and human subject regulations.
    • HTRS is being given unrestricted, irrevocable permission to publish and/or post the abstract in print material, in an online journal partnering with HTRS, on the meeting website, and on the HTRS website. (The first author retains the abstract’s copyright; anyone wishing to use the abstract post-meeting will be instructed to contact the first author for permission.)
  • The presenting author must be willing to answer all questions from the audience in good faith if the abstract is selected for oral presentation.

Review and Selection Process

All abstracts undergo blind peer review. The HTRS Abstract Review Committee evaluates submissions on scientific merit, applicability to current issues in hemostasis and thrombosis,
novelty, and writing quality.

Oral Presentations for Travel Award Recipients

Up to twelve (12) 2023 Travel Awards will be offered to the first authors of outstanding abstracts submitted by trainees and/or early-career investigators. HTRS will select the
abstracts from Travel Award recipients, as designated below, to be presented during one of four oral abstract sessions during the meeting.

  • Presenting authors must be the first authors of selected abstracts.
  • Presenting authors will be given 10 minutes to discuss their abstract, immediately followed by a three-minute question-and-answer period.
  • Details about oral abstract presentation and instructions for preparing slides will be sent to presenting author in December 2022 along with poster presentation instructions.
  • Abstracts selected for oral presentation may also be presented as a poster during the meeting.

Abstracts of Distinction

The top-scoring abstracts submitted by investigators who are not eligible for the Trainee/Early-Career Investigator category and who work for non-commercial institutions will be recognized as “Abstracts of Distinction” for their clinical, basic science/translational, and advanced practice provider research. Authors of abstracts receiving this designation will be invited to give an oral presentation and moderate a roundtable discussion during the “Best of HTRS” Networking Event. Only presenting authors of selected abstracts may give the presentations at the meeting.

  • It is preferred, but not mandated, that the presenting author be the first author of the abstract submitted in this category
  • Presenters will each be given a 10-minute oral presentation to discuss their abstracts, immediately followed by a three-minute question-and-answer period
  • Details about oral abstract presentation and instructions for preparing slides will be sent to the presenting author in November 2022
  • Presenting author(s) will be invited to moderate a roundtable discussion during the “Best of HTRS” Networking Event on Friday, March 10, 2023
  • Presenting author(s) will be invited to the Awards Dinner and Talent Show on Saturday, March 11, 2023, and recognized during the awards programming

Questions about HTRS 2023?

Email [email protected]